dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

CIECA Questionnaires

Sotsiaalministeerium · 18. jaanuar 2019
Viit
1.4-5/205-1
Registreeritud
18. jaanuar 2019
Dokumendi liik
Sissetulev kiri
Adressaat
Maanteemet
Saabumis/saatmisviis
e-post
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-5 Rahvusvahelistele organisatsioonidele saadetavad aruanded ja küsimustikud (sotsiaalharta, sotsiaalkindlustuskoodeksi jm aruanded) (Arhiiviväärtuslik)
Toimik
1.4-5/2019
Vastutaja
Mare Toompuu (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Terviseala asekantsleri vastutusvaldkond, Tervisesüsteemi arendamise osakond)
Lahendamise tähtaeg
18. veebruar 2019

Failid

  • 📎2018-08-QUEST_Medical-Fitness-to-Drive_6 SLEEP APNEA final.pdf622 KB
  • 📎2018-08-QUEST_Medical-Fitness-to-Drive_7 MENTAL DISORDERS final.pdf613 KB
  • 📎2018-08-QUEST_Medical-Fitness-to-Drive_8 NEURODEVELOPMENTAL final.pdf628 KB
  • 📎2018-08-QUEST_Medical-Fitness-to-Drive_9 COMORBIDITY final.pdf650 KB
  • 📎E-kiri.pdf735 KB

Sisu (failidest)

9bd01935-06fd-4211-8bc6-86392ec7d73d9bd01935-06fd-4211-8bc6-86392ec7d73d Re. Questionnaire on Medical Fitness to Drive / Mental disorders Dear Sir or Madam On behalf of CIECA, the International Commission for Driver Testing1, and its Topical Group called ”Setting Standards for the Evaluation of Medical Fitness to Drive”, we would like to send you a questionnaire concerning psychiatric illness/mental health. The CIECA Topical Group ”Setting Standards for the Evaluation of Medical Fitness to Drive” was created in February 2018. One of its aims is to make comparisons between European countries with regards to standards and procedures in evaluating Medical Fitness to Drive. The results of such a comparison will be to find best practices through discussions between representatives from different European countries. Furthermore, the Topical group also aims at giving input to the EU Commission on suggestions for changes in the Annex III of the EU directives and amendments on driver licensing (2006/126/EC; 2009/113/EC; 2014/85/EU; 2016/116) as they are in need of updating in certain areas. The relevant section of the 2006 Directive relating to psychiatric Illness/mental health is attached at the end of this letter and before the questionnaire. Your input to describe the procedures in your country when it comes to psychiatric illness/mental health is very important and we hope that you, by giving this information, will assist in the work to get better and updated EU rules within this field. In this aspect it is especially important that the views of relevant experts (medical doctors, psychologists, etc.) in your organisation are included. If you are not the best person to answer this questionnaire, we hope that you will be able to deliver it to the relevant expert. The information that you provide will be accessed directly only by CIECA employees and members of the “Setting Standards for Evaluation of Medical Fitness to Drive” Topical Group. The data will be coded and uploaded onto a password protected server in CIECA. Your contact details will be accessible only by CIECA employees in compliance with the terms of GDPR regulation. Please note that this questionnaire should be filled in on your computer and returned by e- mail to [email protected] at your earliest convenience, ideally before 15 January 2019. To fill in the questionnaire just click on the grey boxes and start writing. Move to the next question with the TAB key 1 CIECA is the International Commission for Driver Testing, active in the fields of road safety and driver testing. CIECA currently has 72 members in 38 countries worldwide. Its aim is to improve driving standards, contribute to road traffic education, improve road safety, protect the environment and facilitate mobility. More information: www.cieca.eu. 1 9bd01935-06fd-4211-8bc6-86392ec7d73d9bd01935-06fd-4211-8bc6-86392ec7d73d and tick either the Yes or No box ( ) with the space key or with the left mouse button. We would like to thank you in advance for your kind collaboration! Kind regards Dr Lars Englund, Chief Medical Officer of the Swedish Transport Agency and chairman of the CIECA ”Setting Standards for the Evaluation of Medical Fitness to Drive” group CIECA Secretariat Avenue de Tervueren 36-38 B-1040 Brussels T +32 2 732 72 30 www.cieca.eu [email protected] The section of the 2006/126/EC Directive relating to psychiatric Illness/mental health: “MENTAL DISORDERS Group 1: 13.1. Driving licences shall not be issued to, or renewed for, applicants or drivers who suffer from: — severe mental disturbance, whether congenital or due to disease, trauma or neurosurgical operations, — severe mental retardation, — severe behavioural problems due to ageing; or personality defects leading to seriously impaired judgment, behaviour or adaptability, unless their application is supported by authorised medical opinion and, if necessary, subject to regular medical check-ups. Group 2: 13.2. The competent medical authority shall give due consideration to the additional risks and dangers involved in the driving of vehicles covered by the definition of this group.” 2 9bd01935-06fd-4211-8bc6-86392ec7d73d9bd01935-06fd-4211-8bc6-86392ec7d73d QUESTIONNAIRE Please indicate YOUR COUNTRY here: Q 1: How is psychiatric illness (e.g. schizophrenia spectrum and psychotic disorders, depressive and anxiety disorders, bipolar disorders, obsessive-compulsive disorders, trauma and stressor-related disorders, eating disorders, addictive disorders, personality disorder (BUT NOT neurodevelopmental disorders [autism, ADHD and disruptive behaviour disorders which is covered in a separate questionnaire])) notified to the Driving Licensing authority in your country? Give details here: Q 2: Please describe the process from notifying psychiatric illness (e.g. schizophrenia spectrum and psychotic disorders, depressive and anxiety disorders, bipolar disorders, obsessive-compulsive disorders, trauma and stressor-related disorders, eating disorders, addictive disorders, personality disorder (BUT NOT neurodevelopmental disorders [autism, ADHD and disruptive behaviour disorders which is covered in a separate questionnaire])) to obtaining or retaining driving license for group 1 and group 2. Give details here: Q 3: Are on-road driving assessments used as part of the medical fitness to drive process for drivers with psychiatric illness (e.g. schizophrenia spectrum and psychotic disorders, depressive and anxiety disorders, bipolar disorders, obsessive-compulsive disorders, trauma and stressor-related disorders, eating disorders, addictive disorders, personality disorder(BUT NOT neurodevelopmental disorders [autism, ADHD and disruptive behaviour disorders which is covered in a separate questionnaire]))? Yes No Remarks: Q 3a: If so, please describe when on-road driving assessments are used in the medical fitness to drive process for drivers with psychiatric illness. Give details here: Q 3b: If so, please describe which professionals are involved in this. Give details here: 3 9bd01935-06fd-4211-8bc6-86392ec7d73d9bd01935-06fd-4211-8bc6-86392ec7d73d Q 4: Do you feel advice given in the Annex III for psychiatric illness/mental health is adequate and appropriate? Yes No Remarks: Q 5: If your answer is NO then please provide suggestions as to how they should be adapted in following box. Details: Thank you for your cooperation! 4 7299112e-7a0b-40d4-a1e2-ebfcc89d4995 Re. Questionnaire on Medical Fitness to Drive / Neurodevelopmental conditions Dear Sir or Madam On behalf of CIECA, the International Commission for Driver Testing1, and its Topical Group called ”Setting Standards for the Evaluation of Medical Fitness to Drive”, we would like to send you a questionnaire concerning neurodevelopmental conditions starting at young age. The CIECA Topical Group ”Setting Standards for the Evaluation of Medical Fitness to Drive” was created in February 2018. One of its aims is to make comparisons between European countries with regards to standards and procedures in evaluating Medical Fitness to Drive. The results of such a comparison will be to find best practices through discussions between representatives from different European countries. Furthermore, the Topical group also aims at giving input to the EU Commission on suggestions for changes in the Annex III of the EU directives and amendments on driver licensing (2006/126/EC; 2009/113/EC; 2014/85/EU; 2016/116) as they are in need of updating in certain areas. Your input to describe the procedures in your country when it comes to safety impairments due to neurodevelopmental conditions is very important and we hope that you, by giving this information, will assist in the work to get better and updated EU rules within this field. In this aspect it is especially important that the views of relevant experts (medical doctors, psychologists, etc.) in your organisation are included. If you are not the best person to answer this questionnaire, we hope that you will be able to deliver it to the relevant expert. The information that you provide will be accessed directly only by CIECA employees and members of the “Setting Standards for Evaluation of Medical Fitness to Drive” Topical Group. The data will be coded and uploaded onto a password protected server in CIECA. Your contact details will be accessible only by CIECA employees in compliance with the terms of GDPR regulation. Please note that this questionnaire should be filled in on your computer and returned by e- mail to [email protected] at your earliest convenience, ideally before 15 January 2019. To fill in the questionnaire just click on the grey boxes and start writing. Move to the next question with the TAB key 1 CIECA is the International Commission for Driver Testing, active in the fields of road safety and driver testing. CIECA currently has 72 members in 38 countries worldwide. Its aim is to improve driving standards, contribute to road traffic education, improve road safety, protect the environment and facilitate mobility. More information: www.cieca.eu. 1 7299112e-7a0b-40d4-a1e2-ebfcc89d4995 and tick either the Yes or No box ( ) with the space key or with the left mouse button. We would like to thank you in advance for your kind collaboration! Kind regards Dr Lars Englund, Chief Medical Officer of the Swedish Transport Agency and chairman of the CIECA ”Setting Standards for the Evaluation of Medical Fitness to Drive” group CIECA Secretariat Avenue de Tervueren 36-38 B-1040 Brussels T +32 2 732 72 30 www.cieca.eu [email protected] 2 7299112e-7a0b-40d4-a1e2-ebfcc89d4995 QUESTIONNAIRE NEURODEVELOPMENTAL CONDITIONS Please indicate YOUR COUNTRY here: Q 1: How are neurodevelopmental conditions starting at young age notified to the traffic authority in your country? Give details here: Q 2: What kind of diseases are under formal regulation within your country under this term? Attention deficit hyperactivity disorder (ADHD) Attention deficit disorder (ADD) without hyperactivity Asperger´s syndrome Autism Learning Disability Others: Q 3: Under which condition is it allowed to hold a license if a person suffers from severe impairments due to reduced neurodevelopmental conditions? Give details here: 3.a: What are clear cut exclusion criteria? Give details here: Q 4: Are these diseases checked as a regular procedure if a young person applies for the driver licence first time? Yes No Remarks: Q 5: How do you investigate this? Give details here: Q 6: Do you have specific regulations for diseases like ADHD, ADD, Asperger’s syndrome, Autism, Learning Disability? 3 7299112e-7a0b-40d4-a1e2-ebfcc89d4995 Yes No Remarks: If so, 6.a: What are they? Give details here: 6.a.i: Do they differ for Group I and II? Yes No Remarks: 6.b: Do the regulations specifically require the assessment of medical fitness to include any subjective or objective parameters or both? Yes No Remarks: 6.b.i: Which ones, subjective (e.g. anamnesis: experience of symptoms, self reflection, decicion making strategies, triggering factors… or questionnaire or personality test) and objective parameters (e.g., performance tests)? Give details here: 6.c: Do the regulations also specify frequency of follow-up inspections and the proof of continuous medical care? Yes No Remarks: Q 7: Do you have suggestions for grading stages of the disease and therefore different requirements due to fitness to drive? 4 7299112e-7a0b-40d4-a1e2-ebfcc89d4995 Yes No Remarks: Q 8: Do you have specialized medical teams within healthcare system that carry out assessment of medical fitness to drive in cases of deficits in neurodevelopmental conditions? Yes No Remarks: Q 9: Do you have on-road assessment in assessing fitness to drive for patients due to impaired neurodevelopmental conditions? Yes No Remarks: 9.a: If so, how is this done? Give details here: Q 10: Do you find anything special in the directives 2006/126/EC and 2009/113/EC, annex III on neurodevelopmental conditions that you would like to see changed? Yes No Remarks: Thank you for your cooperation! 5 5a4e0dc3-ad38-4f15-ac23-bf591531d711 Re. Questionnaire on Medical Fitness to Drive / Comorbidity Dear Sir or Madam On behalf of CIECA, the International Commission for Driver Testing1, and its Topical Group called ”Setting Standards for the Evaluation of Medical Fitness to Drive”, we would like to send you a questionnaire concerning the issue of comorbidity / multi-pathology. The CIECA Topical Group ”Setting Standards for the Evaluation of Medical Fitness to Drive” was created in February 2018. One of its aims is to make comparisons between European countries with regards to standards and procedures in evaluating Medical Fitness to Drive. The results of such a comparison will be to find best practices through discussions between representatives from different European countries. Furthermore, the Topical group also aims at giving input to the EU Commission on suggestions for changes in the Annex III of the EU directives and amendments on driver licensing (2006/126/EC; 2009/113/EC; 2014/85/EU; 2016/116) as they are in need of updating in certain areas. Your input to describe the procedures in your country when it comes to evaluating fitness to drive taking into account aspects of comorbidity/multi-pathology is very important and we hope that you, by giving this information, will assist in the work to get better and updated EU rules within this field. In this aspect it is especially important that the views of relevant experts (medical doctors, psychologists, etc.) in your organisation are included. If you are not the best person to answer this questionnaire, we hope that you will be able to deliver it to the relevant expert. The information that you provide will be accessed directly only by CIECA employees and members of the “Setting Standards for Evaluation of Medical Fitness to Drive” Topical Group. The data will be coded and uploaded onto a password protected server in CIECA. Your contact details will be accessible only by CIECA employees in compliance with the terms of GDPR regulation. Please note that this questionnaire should be filled in on your computer and returned by e- mail to [email protected] at your earliest convenience, ideally before 15 January 2019. To fill in the questionnaire just click on the grey boxes and start writing. Move to the next question with the TAB key 1 CIECA is the International Commission for Driver Testing, active in the fields of road safety and driver testing. CIECA currently has 72 members in 38 countries worldwide. Its aim is to improve driving standards, contribute to road traffic education, improve road safety, protect the environment and facilitate mobility. More information: www.cieca.eu. 1 5a4e0dc3-ad38-4f15-ac23-bf591531d711 and tick either the Yes or No box ( ) with the space key or with the left mouse button. We would like to thank you in advance for your kind collaboration! Kind regards Dr Lars Englund, Chief Medical Officer of the Swedish Transport Agency and chairman of the CIECA ”Setting Standards for the Evaluation of Medical Fitness to Drive” group CIECA Secretariat Avenue de Tervueren 36-38 B-1040 Brussels T +32 2 732 72 30 www.cieca.eu [email protected] 2 5a4e0dc3-ad38-4f15-ac23-bf591531d711 QUESTIONNAIRE Comorbidity: There is no agreement on the meaning of the term. Related constructs are multimorbidity, morbidity burden, and patient complexity. Comorbidity is here defined as the presence of one or more additional mental, neurodevelopmental, medical, or physical conditions, diseases or disorders co-occurring with (that is, concomitant or concurrent with) a primary condition, disease or disorder. It here is interpreted as the notion of burden of illness or disease, defined by the total burden of dysfunction and is therefore linked to the concept of total impact on patient-reported outcomes, including functioning. Hence, the comorbidity concept, as referred to here, reflects not only the multiplicity of conditions, but also the interactions between them, influencing the total burden of dysfunction. This total burden is influenced not only by health-related characteristics, but also by socioeconomic, cultural, environmental, and patient behaviour characteristics. Comorbidity is associated with worse health outcomes, more complex clinical management, and increased health care costs. Please indicate YOUR COUNTRY here: Q 1: Can your country, in its fitness to drive decision process, take into account the issue of comorbidity (as defined above)? In other words: Is there any way of taking this into account in any fitness to drive procedure, recommendation or decision? Yes No Give details here: Q 2: Does your country, in its legally defined fitness to drive requirements/ national guidelines, take into account the issue of comorbidity (as defined above)? Yes No Give details here: Q 3: Does your country, in its requirements pertaining to medical assessment, take into account the issue of comorbidity (as defined above)? Yes No Not applicable 3 5a4e0dc3-ad38-4f15-ac23-bf591531d711 Give details here: Q 4: Does your country, in its requirements pertaining to psychological assessment, take into account the issue of comorbidity (as defined above)? Yes No Not applicable Give details here: Q 5: Does your country, in its requirements pertaining to practical driving assessment take into account the issue of comorbidity (as defined above)? Yes No Not applicable Give details here: Q 6: Are you aware of any method of quantification of the concept of comorbidity as defined above? Yes No Give details here: Q 7: Can any undocumented issue of comorbidity pose a problem related to professional or medical secrecy? (For example, in case an issue of comorbidity is discovered but this was not the primary reason for the fitness to drive evaluation.) Yes No Give details here: Thank you for your cooperation! 4 8019e8d3-7ad9-44fa-b440-e43e6fb49cef Re. Questionnaire on Medical Fitness to Drive / Sleep apnea Dear Sir or Madam On behalf of CIECA, the International Commission for Driver Testing1, and its Topical Group called ”Setting Standards for the Evaluation of Medical Fitness to Drive”, we would like to send you a questionnaire concerning sleep apnea. The CIECA Topical Group “Setting Standards for the Evaluation of Medical Fitness to Drive” was created in February 2018. One of its aims is to make comparisons between European countries with regards to standards and procedures in evaluating Medical Fitness to Drive. The results of such a comparison will be to find best practices through discussions between representatives from different European countries. Furthermore, the Topical group also aims at giving input to the EU Commission on suggestions for changes in the Annex III of the EU directives and amendments on driver licensing (2006/126/EC; 2009/113/EC; 2014/85/EU; 2016/116) as they are in need of updating in certain areas. Your input to describe the procedures in your country when it comes to sleep apnea is very important and we hope that you, by giving this information, will assist in the work to get better and updated EU rules within this field. In this aspect it is especially important that the views of relevant experts (medical doctors, psychologists, etc.) in your organisation are included. If you are not the best person to answer this questionnaire, we hope that you will be able to deliver it to the relevant expert. The information that you provide will be accessed directly only by CIECA employees and members of the “Setting Standards for Evaluation of Medical Fitness to Drive” Topical Group. The data will be coded and uploaded onto a password protected server in CIECA. Your contact details will be accessible only by CIECA employees in compliance with the terms of GDPR regulation. Please note that this questionnaire should be filled in on your computer and returned by e- mail to [email protected] at your earliest convenience, ideally before 15 January 2019. To fill in the questionnaire just click on the grey boxes and start writing. Move to the next question with the TAB key 1 CIECA is the International Commission for Driver Testing, active in the fields of road safety and driver testing. CIECA currently has 72 members in 38 countries worldwide. Its aim is to improve driving standards, contribute to road traffic education, improve road safety, protect the environment and facilitate mobility. More information: www.cieca.eu. 1 8019e8d3-7ad9-44fa-b440-e43e6fb49cef and tick either the Yes or No box ( ) with the space key or with the left mouse button. We would like to thank you in advance for your kind collaboration! Kind regards Dr Lars Englund, Chief Medical Officer of the Swedish Transport Agency and chairman of the CIECA ”Setting Standards for the Evaluation of Medical Fitness to Drive” group CIECA Secretariat Avenue de Tervueren 36-38 B-1040 Brussels T +32 2 732 72 30 www.cieca.eu [email protected] 2 8019e8d3-7ad9-44fa-b440-e43e6fb49cef QUESTIONNAIRE Please indicate YOUR COUNTRY here: Q 1: How is sleep apnea notified to the authority in your country? Give details here: Q 2: Under which conditions are drivers with sleep apnea allowed to hold a license? Give details here: Q 3: How do you investigate this? Give details here: Q 4: Do you have specific regulations for narcolepsy or other central disorders of hypersomnolence (idiopathic hypersomnia, Klein-Levin syndrome)? Yes No Remarks: If so, 4.a: Which diseases are covered by the specific regulations? Give details here: 4.a.i: Do the regulations differ for Group I and II? Yes No Remarks: 4.b: Do the regulations require that assessment of medical fitness includes assessment of subjective or objective parameters or both? If so, which ones? No requirement in the regulations Yes, subjective parameters to be assessed Yes, objective parameters to be assessed 3 8019e8d3-7ad9-44fa-b440-e43e6fb49cef Yes, both subjective and objective parameters to be assessed Remarks: 4.c: Do the regulations cover the use of any medication for narcolepsy? Yes No Remarks: 4.d: Do the regulations also specify frequency of follow ups? Yes No Remarks: Q 5: Do you have any suggestions for what a relevant regulation for narcolepsy and/or other central disorders of hypersomnolence should include? If yes, give details here: Q 6: Do you have specialized medical teams within the healthcare system that carry out assessment of medical fitness to drive when it comes to sleep apnea or narcolepsy? Yes No Remarks: Q 7: Do you have on-road assessment when assessing fitness to drive for patients with sleep apnea or narcolepsy? Yes No Remarks: 7.a: If so, how is on-road assessment done (eg length, content, procedure)? Give details here: 4 8019e8d3-7ad9-44fa-b440-e43e6fb49cef Q 8: Is there anything specific in the directives 2006/126/EC and 2009/113/EC, annex III on sleep apnea and narcolepsy that you would like to see changed? Yes No If yes, give details here: If no, please explain why: Thank you for your cooperation! 5 Saatja: Kairi Kimber <[email protected]> Saadetud: 18.01.2019 09:42 Adressaat: SM Info <[email protected]> Teema: CIECA Questionnaires - Fitness to Drive evaluation procedure (batch 2) Tähtsus: Kõrgeim Manused: 2018-08-QUEST_Medical-Fitness-to-Drive_6 SLEEP APNEA final.doc; 2018-08- QUEST_Medical-Fitness-to-Drive_7 MENTAL DISORDERS final.doc; 2018-08- QUEST_Medical-Fitness-to-Drive_8 NEURODEVELOPMENTAL final.doc; 2018-08- QUEST_Medical-Fitness-to-Drive_9 COMORBIDITY final.doc Tere CIECA on saatnud maanteeametile neli k�simustikku. Kuna k�simused on meditsiinivaldkonnast, siis palume teil neile vastata ja meile tagasi saata hiljemalt 18.02.2019. Kirjas on palutud t�itmiseks kaasata ka arste. Lugupidamisega Kairi Kimber peaspetsialist | eksamiosakond 636 1113 | [email protected] Maanteeamet Teelise 4 | 10916 Tallinn From: Blanka Wirth <[email protected]> Sent: Wednesday, January 16, 2019 11:49 AM Cc: Augusta Sica <[email protected]> Subject: Reminder: CIECA Questionnaires - Fitness to Drive evaluation procedure (batch 2) Importance: High Dear CIECA contact person We would like to kindly remind you of the four questionnaires regarding the Fitness To Drive evaluation procedure (batch 2, see attached) that were sent on behalf of the CIECA Topical Group� Setting Standards for the Evaluation of Medical Fitness to Drive�. The results of the questionnaires are planned to be presented at the next meeting of the group on 11 March 2019. Please be also reminded that it is especially important to include in this process medical doctors that are involved in medical driver fitness issues. Thank you very much in advance for your collaboration! Kind regards -------------------------------------- Blanka Wirth CIECA T +32 2 732 72 30 www.cieca.eu [email protected]  Before printing this email, assess if it is really needed
Allikas: Sotsiaalministeerium dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel